Narodowy Instytut Onkologii Im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy Research institute

Other research and experimental development on natural sciences and engineering

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-12-30
Activity description

Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie is Poland’s largest oncology center, based in Warsaw with branches in Kraków and Gliwice. It provides cancer diagnostics and treatment, comprehensive patient care, and conducts research, including more than 500 clinical trials.

Registered address
ul. Wilhelma Konrada Roentgena 5, 02-781 Warszawa, Poland
Website
Email
Phone
Social media
Electronic delivery address
AE:PL-97169-45195-SUGIS-30

Financials

Revenue history (in m)

From the notes

Current income tax (CIT due)$406,206

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 68 days for 2021). All were audited by a statutory auditor.

  • 202510/07/2026
  • 202410/07/2025
  • 202320/06/2024
  • 202228/06/2023
  • 202121/09/2022
  • 202020/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top <1%
Voivodeship · Mazowieckie108 / 142,204
Top <1%
Country · Poland245 / 496,474
Top <1%

Results vs industry

Revenue
This companyUSD 813.36mMedianUSD 73.13kAverageUSD 3.24m
Net profit
This companyUSD 24.57mMedianUSD 69.70AverageUSD 83.06k
Operating costs
This companyUSD 776.36mMedianUSD 75.83kAverageUSD 3.05m
Assets
This companyUSD 499.42mMedianUSD 120.25kAverageUSD 3.90m

Website technology

Analytics and marketing
  • Google Analytics
  • Google Tag Manager
  • Meta Pixel
Hosting and server
  • Cloudflare

Public procurement

17 tenders recorded as contractor: 3 national ($41,356) and 14 EU ($2,018,207), and 4035 as contracting authority (2356 national and 1679 EU).

SubjectAmount
CP.251.1168.2026, comprehensive educational service involving the organisation of courses for doctors participating in specialist training, carried out for the project „Wspieranie kształcenia podyplomowego lekarzy w dziedzinach istotnych z punktu widzenia potrzeb epidemiologiczno-demograficznych Polski (FERS1)”, co-financed by the ESF
$19,500
CP.251.791.2026, comprehensive educational service involving the organisation of courses for physicians participating in specialist training, provided for the project “Supporting postgraduate training of physicians in fields relevant to Poland’s epidemiological and demographic needs (FERS1)”, co-financed by the ESF
$27,783
CP-251-131/2026, comprehensive educational service involving the organisation of courses for doctors participating in specialist training, delivered for the project titled „Wspieranie kształcenia podyplomowego lekarzy w dziedzinach istotnych z punktu widzenia potrzeb epidemiologiczno-demograficznych Polski (FERS1)”, co-financed by the ESF
$194.4K

National Health Fund (NFZ) contracts

The institute has been an NFZ healthcare provider since 2008. In 2026 it is performing 27 contracts with a total value of USD 794.23m. All its contracts were worth USD 6.76bn in total.

NFZ contract value by year (in m USD)

Type of careNFZ branchContractsValue in 2026
Inpatient treatmentmazowieckie4USD 400.63m
Inpatient treatmentśląskie6USD 291.03m
Inpatient treatmentmałopolskie4USD 97.72m
Preventive health programmesśląskie1USD 977.98k
Preventive health programmesmazowieckie3USD 770.31k

NFZ waiting lists

This company's facilities run 389 NFZ waiting lists. Waiting time forecast by NFZ, as of 16.11.2026.

ServiceWaiting time
Genetic testingno wait
Nuclear medicine examinationsno wait
Hip arthroplastyno wait
Knee joint replacementno wait
Treatment of patients with Ph(-) myeloproliferative neoplasmsno wait

Trademarks

The institute holds 6 active trademarks registered with the Polish Patent Office. The first mark was filed in 2024.

MarkNumberClassesStatusProtected until
b Z.57640735, 39, 42Protected Nov 5, 2034
b Z.57641035, 39, 42Protected Nov 5, 2034
b Z.57641335, 39, 42Protected Nov 5, 2034
biobank Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy Z.57641535, 39, 42Protected Nov 5, 2034
biobank Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy Z.57641635, 39, 42Protected Nov 5, 2034
MarkProtected until
b Nov 5, 2034
b Nov 5, 2034
b Nov 5, 2034
biobank Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy Nov 5, 2034
biobank Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy Nov 5, 2034

Beneficial owners

No beneficial owners recorded for the entity Narodowy Instytut Onkologii Im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy.

Bank accounts

Registered as a VAT taxpayer on 2003-12-31.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Land (incl. perpetual usufruct)
$10.9M
Buildings and premises
$102.5M

Public aid

14 public aid cases recorded, with a total value of $1,978,124.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$34,126
De minimis aid (in accordance with Commission Regulation 2023/2831)
$51,952
Investment aid for research infrastructures
$616.9K

European Funds

43 projects recorded: 1 from FE lists ($364,912) and 42 Commission grants (FTS) ($7,553,789).

ProjectEU co-financing
Joint action personalised cancer medicine
$667.8K
Improving quality and timeliness of cancer registry data feeding into the european cancer information system
$268.5K
Enhancing the digital capabilities of cancer centres in europe to improve prevention and care
$334.6K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Change history

DateEvent
2020-01-22Address change
2020-01-22Name change
2016-07-21PKD change
2014-12-08Address change
2011-04-22Name change

FAQ

Last updated: 2026-07-15